Liver News and Research

RSS

Wild boars and Hepatitis E: Whats the zoonotic risk?

The prevalence of the Hepatitis E virus (HEV) in the Portuguese wild boar population.

4 Sep 2023

Mycotoxin contamination is still a serious food/feed safety issue

The updated and most recent evidence of the occurrence and co-occurrence of mycotoxins.

4 Sep 2023

Early life high fructose exposure is associated with increased prevalence of adolescent anxiety disorders

Researchers investigated whether exposure to high fructose in early life directly affects essential microglia function.

4 Sep 2023

Machine learning helps identify metabolic biomarkers that could predict cancer risk

A novel study from the University of South Australia has identified a range of metabolic biomarkers that could help predict the risk of cancer.

4 Sep 2023

Students starting school and college in September are at increased risk of serious illnesses

A leading testing expert fears a perfect storm of infections in September as students start at schools and colleges. School closures during Covid lockdowns mean 1-in-8 students starting university this year remains unprotected against meningitis. Concern is growing early symptoms may be confused with freshers’ flu.

4 Sep 2023

Scientists discover new role for liver tPA in regulating cholesterol levels

Despite advances in treatment for high cholesterol, heart disease remains the leading cause of death in the U.S. Scientists at the Medical College of Wisconsin (MCW) are investigating the role of a form of cholesterol called very-low-density lipoprotein – and their findings may lead to new treatment options in the future.

1 Sep 2023

Amgen to discuss application for LUMAKRAS® (sotorasib) for the treatment of KRAS G12C-positive NSCLC at FDA advisory committee meeting

Amgen today announced the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) will review data supporting the supplemental New Drug Application (sNDA) for the full approval of LUMAKRAS® (sotorasib) for adults with previously treated locally advanced or metastatic KRAS G12C-mutated non-small cell lung cancer (NSCLC) at a meeting on Oct. 5, 2023.

From AMGEN 1 Sep 2023

The efficacy and safety of anti-androgens in the management of hormonal and clinical features of PCOS

The safety and efficacy of anti-androgens in managing polycystic ovary syndrome (PCOS).

1 Sep 2023

Study shows strong link between depression and inflammation in obese patients before and after bariatric surgery

Research funded by the National Institute for Health and Care Research (NIHR) has shown that higher levels of inflammation in the blood of patients with obesity undergoing bariatric surgery predicts poorer weight loss six months after the procedure.

31 Aug 2023

New gene therapy offers hope for beta thalassemia patients

UCSF Benioff Children's Hospital Oakland provides new therapy to first patient since FDA approval.

31 Aug 2023

Exploring the role of the metabolic syndrome in individual mechanisms of liver fibrosis

Chronic liver injury results in the development of liver fibrosis in approximately 25% of individuals in response to diverse insults, and several aspects of the development of liver injury appear to be common to a variety of initiating factors.

31 Aug 2023

A type of gut bacteria may protect against the development of obesity and type-2 diabetes

Researchers led by Hiroshi Ohno at the RIKEN Center for Integrative Medical Sciences (IMS) in Japan have discovered a type of gut bacteria that might help improve insulin resistance, and thus protect against the development of obesity and type-2 diabetes.

31 Aug 2023

Mediterranean diet with a dairy twist shows promise in lowering heart disease risk

An 8-week study found that a Mediterranean diet supplemented with dairy foods altered specific gut bacteria and positively impacted systolic blood pressure in Australians at high risk of cardiovascular disease. The findings suggest that this MedDairy diet could be an effective strategy for reducing cardiovascular risks.

31 Aug 2023

U.S. teens vaping CBD at alarming rates: Study reveals surprising factors behind trend

The recent JAMA Network Open study finds a significant prevalence of CBD vaping among U.S. adolescents, with higher rates among Hispanic and sexual minority youth. The study calls for targeted educational campaigns and stricter regulations to curb this growing trend.

30 Aug 2023

Engineered ACE2 decoy shows promise as COVID-19 treatment

Researchers from Japan demonstrated that an engineered angiotensin-converting enzyme 2 (ACE2) receptor, which showed the potential to remarkably reduce the emergence of resistant virus strains, could successfully exert its therapeutic effect in primates, which may open avenues for the application of the technology for the treatment of humans.

30 Aug 2023

Study suggests whole egg consumption has benefits over egg white consumption in young, healthy adults

Researchers investigated the impacts of different egg-based diets on healthy young individuals' immune, hematologic, and metabolic clinical profiles.

30 Aug 2023

CN Bio appoints Dr. Tomasz Kostrzewski as Chief Scientific Officer

CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced the appointment of Dr. Tomasz Kostrzewski as Chief Scientific Officer.

From CN Bio 30 Aug 2023

Higher dose and shorter treatment of key antibiotic proven to be safe for TB patients

A higher dose and shorter treatment time of a cornerstone tuberculosis (TB) drug has proven to be safe for patients, according to a clinical trial led by researchers at St George's, University of London and results published in NEJM Evidence.

29 Aug 2023

Drug-encapsulated nanogels show potential for treating obesity and other liver diseases

A University of Massachusetts Amherst biomedical engineer has used a nanogel-based carrier designed in his lab to deliver a drug exclusively to the liver of obese mice, effectively reversing their diet-induced disease.

29 Aug 2023

Inorganic nitrate reduces contrast-induced nephropathy in high-risk patients

Inorganic nitrate reduces contrast-induced nephropathy (CIN), improves renal outcomes and reduces cardiac events compared to placebo in patients at risk of renal injury undergoing coronary angiography for acute coronary syndrome, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

29 Aug 2023

Liver News and Research

Wild boars and Hepatitis E: Whats the zoonotic risk?

Mycotoxin contamination is still a serious food/feed safety issue

Early life high fructose exposure is associated with increased prevalence of adolescent anxiety disorders

Machine learning helps identify metabolic biomarkers that could predict cancer risk

Students starting school and college in September are at increased risk of serious illnesses

Scientists discover new role for liver tPA in regulating cholesterol levels

Amgen to discuss application for LUMAKRAS® (sotorasib) for the treatment of KRAS G12C-positive NSCLC at FDA advisory committee meeting

The efficacy and safety of anti-androgens in the management of hormonal and clinical features of PCOS

Study shows strong link between depression and inflammation in obese patients before and after bariatric surgery

New gene therapy offers hope for beta thalassemia patients

Exploring the role of the metabolic syndrome in individual mechanisms of liver fibrosis

A type of gut bacteria may protect against the development of obesity and type-2 diabetes

Mediterranean diet with a dairy twist shows promise in lowering heart disease risk

U.S. teens vaping CBD at alarming rates: Study reveals surprising factors behind trend

Engineered ACE2 decoy shows promise as COVID-19 treatment

Study suggests whole egg consumption has benefits over egg white consumption in young, healthy adults

CN Bio appoints Dr. Tomasz Kostrzewski as Chief Scientific Officer

Higher dose and shorter treatment of key antibiotic proven to be safe for TB patients

Drug-encapsulated nanogels show potential for treating obesity and other liver diseases

Inorganic nitrate reduces contrast-induced nephropathy in high-risk patients

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News